When using research peptides, you take on responsibility for proper reconstitution, dosing calculations, and sterile injection technique
It's an investigational drug currently in Phase 3 clinical trials
The CMS Electronic Prior Authorization Acceleration Initiative (May 13, 2026) On May 13, 2026, CMS announced the Electronic Prior Authorization Acceleration Initiative with 29 healthcare organizations as early adopters
Water, Centella Asiatica Extract (20.5%), Butylene Glycol, Glycerin, Dipropylene Glycol, Niacinamide (20,000ppm), Hydroxyethyl Urea, Sodium Hyaluronate, Allantoin, Panthenol, Glutathione (1,000ppm), Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Beta-Glucan, Hippophae Rhamnoides Fruit Extract, Adenosine, Madecassic Acid, Asiaticoside, Asiatic Acid, Squalane, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Glyceryl Stearate, Cholesterol, Xanthan Gum, Propanediol, Hydroxyacetophenone, 1,2-Hexanediol, Ethylhexylglycerin, Dipotassium Glycyrrhizate, Styrene/Acrylates Copolymer, Citric Acid, Sodium Citrate *For the most recent ingredient list, please consult the product packaging or contact us for a product photo.
